Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 1 37-1, 1998, Pages

  Castle, Arthur L ^a   Kuo, Chia Hua ^a   Ivy, John L ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Glucose 6 phosphate; Glucose uptake; Glycogen; Skeletal muscle

Indexed keywords

AMYLIN; CYCLIC AMP; DEOXYGLUCOSE; GLUCOSE; SALCATONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; GLYCOLYSIS; MALE; METABOLIC REGULATION; MUSCLE METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031911330     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.1.e6     Document Type: Article

References (34)

1. Ariano, M. A., R. B. Armstrong, and V. R. Edgerton. Hindlimb muscle fiber populations of five mammals. J. Histochem. Cytochem. 21: 51-55, 1973.
2. Beaumont, K., R. A. Pittner, C. X. Moore, D. Wolfe-Lopez, K. S. Prickett, A. A. Young, and T. J. Rink. Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved. Br. J. Pharmacol. 115: 713-715, 1995.
3. Butler, P. C., J. Chou, W. B. Carter, Y. N. Wang, B. H. Bu, D. Chang, J. K. Chang, and R. A. Rizza. Effects of meal ingestion on plasma amylin concentration in NIDDM and nondiabetic humans. Diabetes 39: 752-756, 1990.
4. Cooper, G. J., A. C. Wilis, A. Clark, R. C. Turner, R. B. Slim, and K. B. Reid. Purification and characterization of a peptide from amylin-rich pancreases of type 2 diabetic patients. Proc. Natl. Acad. Sci. USA 84: 8628-8632, 1987.
5. Deems, R. O., R. W. Deacon, and D. A. Young. Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem. Biophys. Res. Com. 174: 716-720, 1991.
6. Etgen, G. J., Jr., J. T. Brozinick, Jr., H. Y. Kang, and J. L. Ivy. Effects of exercise training on skeletal muscle glucose uptake and transport. Am. J. Physiol. 264 (Cell Physiol. 33): C727-C733, 1993.
7. Frontoni, S., S. B. Choi, D. Banduch, and L. Rossetti. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes 40: 568-573, 1991.
8. Gilman, A. G. A protein binding assay for adenosine 3′: 5′ cyclic monophosphate. Proc. Natl. Acad. Sci. USA 67: 305-312, 1970.
9. Hohorst, H. J. Determination of L-lactate with LDH and DPH. In: Methods of Enzymatic Analysis. New York: Academic, 1965, p. 265-270.
10. Inoue, K., A. Hisatomi, F. Umeda, and H. Nawata. Amylin release from perfused rat pancreas in response to glucose and arginine. Diabetes Res. Clin. Pract. 10: 189-192, 1990.
11. Ivy, J. L., W. M. Sherman, C. L. Cutler, and A. L. Katz. Exercise and diet reduce muscle insulin resistance in obese Zucker rat. Am. J. Physiol. 251 (Endocrinol. Metab. 14): E299-E305, 1986.
12. Kenney, M. A., C. X. Moore, R. Pittner, and K. Beaumont. Salmon calcitonin binding and stimulation of cyclic AMP generation in rat skeletal muscle. Biochem. Biophys. Res. Commun. 197: 8-14, 1993.
13. Kim, J. K., and J. H. Youn. Prolonged suppression of glucose metabolism causes insulin resistance in rat skeletal muscle. Am. J. Physiol. 272 (Endocrinol Metab. 35): E288-E296, 1997.
14. Kolterman, O. G., A. Gottlieb, C. Moyses, and W. Colburn. Reduction of postprandial hyperglycemia in subjects with IDDM by intravenous infusion of AC137, a human amylin analogue. Diabetes Care 18: 1179-1182, 1995.
15. Kreutter, D., S. J. Orena, A. J. Torchia, W. Soeller, and R. W. Stevenson. Amylin mRNA and plasma peptide levels in animal models of NIDDM (Abstract). Diabetes 40: 159A, 1991.
16. Kreutter, D. K., S. J. Orena, A. J. Torchia, L. G. Contillo, G. C. Andrews, and R. W. Stevenson. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E606-E613, 1993.
17. Lawrence, J. C., Jr., and J. N. Zhang. Control of glycogen synthase and phosphorylase by amylin in rat skeletal muscle. Hormonal effects on the phosphorylation of phosphorylase and on the distribution of phosphate in the synthase subunit. J. Biol. Chem. 269: 11595-11600, 1994.
18. Leighton, B., and G. J. Cooper. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature 335: 632-635, 1988.
19. Leighton, B., and E. Foot. The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo. Biochem. J. 269: 19-23, 1990.
20. Lowry, O. H., and J. V. Passouneau. A Flexible System of Enzymatic Analysis. New York: Academic, 1972.
21. Mészáros, K., C. H. Lang, D. M. Hargrove, and J. J. Spitzer. Tissue glucose utilization during epinephrine-induced hyperglycemia. J. Appl. Physiol. 67: 1770-1775, 1989.
22. Passouneau, J. V., and V. R. Lauderdale. A comparison of three methods of glycogen measurement in tissue. Anal. Biochem. 60: 404-412, 1974.
23. Pittner, R., K. Beaumont, A. Young, and T. Rink. Dose-dependent elevation of cyclic AMP, activation of glycogen phosphorylase, and release of lactate by amylin in rat skeletal muscle. Biochem. Biophys. Acta 1267: 75-82, 1995.
24. Pittner, R. A., D. Wolfe-Lopez, A. A. Young, and T. J. Rink. Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle. FEBS Lett. 365: 98-100, 1995.
25. Poyner, D. Pharmacology of receptors for calcitonin gene-related peptide and amylin. Trends Pharmacol. Sci. 16: 424-428, 1995.
26. Rink, T. J., K. Beaumont, J. Koda, and A. Young. Structure and biology of amylin. Trends Pharmacol. Sci. 14: 113-118, 1993.
27. 14C]glucose method. Int. J. Rad. Appl. Instrum. B. 18: 157-166, 1991.
28. Sherman, W. M., A. L. Katz, C. L. Cutler, R. T. Withers, and J. L. Ivy. Glucose transport: locus of muscle insulin resistance in obese Zucker rats. Am. J. Physiol. 255 (Endocrinol. Metab. 18): E374-E382, 1988.
29. Vine, W., P. Smith, R. LaChappell, T. J. Rink, and A. A. Young. Lactate production from the rat hindlimb is increased after glucose administration and is suppressed by a selective amylin antagonist: evidence for action of endogenous amylin in skeletal muscle. Biochem. Biophys. Res. Comun. 216: 554-559, 1995.
30. Young, A. A., G. J. S. Cooper, P. Carlo, T. J. Rink, and M. W. Wang. Response to intravenous injections of amylin and glucagon in fasted, fed, and hypoglycemic rats. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E943-E950, 1993.
31. Young, A. A., B. Gedulin, L. S. Gaeta, K. S. Prickett, K. Beaumont, E. Larson, and T. J. Rink. Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the rat. Evidence for a metabolic role of endogenous amylin. FEBS Lett. 343: 237-241, 1994.
32. Young, A. A., B. Gedulin, D. Wolfe-Lopez, H. E. Greene, T. J. Rink, and G. J. S. Cooper. Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists. Am. J. Physiol. 263 (Endocrinol. Metab. 26): E274-E281, 1992.
33. Young, D. A., R. O. Deems, R. W. Deacon, R. H. McIntosh, and J. E. Foley. Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am. J. Physiol. 259 (Endocrinol. Metab. 22): E457-E461, 1990.
34. Zierath, J. R., D. Galuska, A. Engstrom, K. H. Johnson, C. Betsholtz, P. Westermark, and H. Wallberg-Henriksson. Human islet amyloid polypeptide at pharmacological levels inhibits insulin and phorbol ester-stimulated glucose transport in vitro incubated human muscle strips. Diabetologia 35: 26-31, 1992.